Marker Therapeutics MRKR
NASDAQ MRKR
$1.07 -0.06 (-5.31%)
At close: Oct 22, 2026 · 4:00 PM EDT

Marker Therapeutics (MRKR) Other financing activities (2010 - 2015)

Updated

Marker Therapeutics (MRKR) posted Other financing activities of $60,793 for Q4 2011, down 23.2% from the prior quarter.

Analysis

Marker Therapeutics (MRKR) Other financing activities (2010 - 2015) Analysis & Trends

For FY2011, Marker Therapeutics' Other financing activities came in at $140,000.

  • The Q4 2011 figure stands as the lowest quarterly Other financing activities since Q3 2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Marker Therapeutics 20.86 Mn -39.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 1.00
Sep 30, 2015 -102,986.00
Dec 31, 2011 5,819.00
Sep 30, 2011 134,181.00
Sep 30, 2010 -61,996.00
API Access

Marker Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=MRKR&period=max&api_key=YOUR_API_KEY